Swiss National Bank

Bank

Position in APGE — Apogee Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in APGE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$10,180,391

+$3,817,139 QoQ

Shares Held

76,700

+1.5% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#89

of 288 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. APGE ranks #32 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,180,391	76,700	+1.5%	Shares	Sole	2026-08-11
2026-03-31	$6,363,252	75,600	+20.2%	Shares	Sole	2026-05-07
2025-12-31	$4,747,692	62,900	+44.9%	Shares	Sole	2026-02-12
2025-09-30	$1,724,282	43,400	+1.9%	Shares	Sole	2025-11-13
2025-06-30	$1,850,118	42,600	-2.3%	Shares	Sole	2025-08-12
2025-03-31	$1,628,896	43,600	-1.6%	Shares	Sole	2025-05-12
2024-12-31	$2,006,790	44,300	+17.5%	Shares	Sole	2025-02-10
2024-09-30	$2,214,498	37,700	-10.7%	Shares	Sole	2024-11-07
2024-06-30	$1,660,570	42,200	+2.2%	Shares	Sole	2024-08-08
2024-03-31	$2,744,385	41,300	+25.2%	Shares	Sole	2024-05-07
2023-12-31	$922,020	33,000	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.